Clinical trials: Moderate to Severe Midface Volume Deficit, open to volunteers
Moderate to Severe Midface Volume Deficit
Post-Approval Study of Saypha® ChIQ™ for Midface Augmentation in Subjects With Fitzpatrick Skin Types V and VI
The goal of this clinical trial is to further characterize the safety profile of saypha® ChIQ™ for midface augmentation in adults with Fitzpatrick Skin Types V and VI who have moderate to severe midface volume deficit.
- Trial name
- Volido PAS (NCT07918443)
- Testing
- Crosslinked hyaluronic acid dermal filler with lidocaine
- Volunteers
- 45 people, healthy volunteers welcome
- Sponsor
- Croma-Pharma GmbH